Bioavailability Study of Candesartan Cilexetil 16mg Tablet Under Fasting Conditions
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to GlaxoSmithKline
Related studies linked through entity extraction aliases.
Bioavailability Study of Candesartan Cilexetil 8mg Tablet Under Fasting Conditions
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Investigate the Safety and Pharmacokinetics of a Single Dose of GSK2256294 in Healthy Young Males and Elderly Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV .
- Status
- COMPLETED
- Phase
- PHASE3
Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Darapladib China PK
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Investigate the Recovery, Excretion and Pharmacokinetics of [14C]-GSK2140944 Administered as a Single Intravenous and Single Oral Dose to Healthy Adult Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
FluLaval® Quadrivalent Pregnancy Registry
- Status
- WITHDRAWN
- Phase
- N/A
Safety and Tolerability Study of GSK2586184 in Patients With Moderate to Severely Active Ulcerative Colitis.
- Status
- TERMINATED
- Phase
- PHASE1
A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS)
- Status
- COMPLETED
- Phase
- PHASE2
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3206641A and GSK3206640A Administered in Adults 18 to 64 Years of Age
- Status
- COMPLETED
- Phase
- PHASE1
Individualizing Pazopanib Therapy by exploRing the Role of Early Metabolic responsE and Drug Exposure as a preDICTor for Treatment Outcome in Patients With STS
- Status
- COMPLETED
- Phase
- N/A
A Prospective, Epidemiological Study to Assess the Disease Burden of Respiratory Syncytial Virus Associated, Suspected Lower Respiratory Tract Infections in Newborns, From 0 to 2 Years of Age and Risk of Development of Wheeze and Asthma From 0 to 6 Years of Age
- Status
- COMPLETED
- Phase
- NA
Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.
- Status
- COMPLETED
- Phase
- PHASE3
Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Safety of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Healthy Vietnamese Children
- Status
- COMPLETED
- Phase
- PHASE3
Combined Modality Treatment of Sarcomas of the Extremities
- Status
- COMPLETED
- Phase
- PHASE1
Study to Investigate the Irritation Potential of GSK1940029 Gel
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Pharmacokinetic Profile of Salbutamol Delivered by Unit Dose Dry Powder Inhaler (UD-DPI) Compared to the Diskus and Metered Dose Inhaler (MDI) in Healthy Volunteers.
- Status
- COMPLETED
- Phase
- PHASE1
Single Dose Escalation Trial to Evaluate the Safety, Tolerability Pharmacokinetics and Pharmacodynamics of GSK3050002
- Status
- COMPLETED
- Phase
- PHASE1